Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds – Science Daily

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and…

Click here to view the original article.